StableHOCL™ · Flagship platform

Discovered in 1834.
Made stable in 2026.

The molecule the world has wanted for a century — finally manufacturable, shippable, and ready to scale.

The problem it solves

A 190-year-old ideal, held back by one barrier.

Hypochlorous acid is among the most powerful and safest antimicrobial agents known to science. It is not a synthetic invention; it is the same molecule the human immune system produces to defend itself. It works across a broad spectrum (bacteria, viruses, fungi, spores, and biofilm) and breaks down into nothing more than salt and water, leaving no toxic residue.

For nearly two centuries, one barrier held it back: it would not stay stable. Conventional hypochlorous acid begins to degrade within days and carries a shelf life of roughly thirty days, too short to manufacture, store, and ship at scale.

Discovered 1834

StableHOCL™ solves that. It is a proprietary, patent-pending platform that delivers hypochlorous acid in a stable, fully potent form with a 24-month shelf life: manufacturable, storable, and shippable worldwide.

Documented to be up to 100 times more effective than antimicrobial bleach, it stays gentle on stainless steel and most surfaces and breaks down to nothing more than salt and water. The significance is structural, not incremental: by solving stability, StableHOCL™ turns a 190-year-old scientific ideal into a platform deployable across the many fields where a safe, potent, residue-free antimicrobial has always been wanted but never been practical.

Documented, data-backed

24mo
Shelf life, fully potent, versus ~30 days for conventional HOCl
100×
Up to 100× the antimicrobial effectiveness of bleach
5
Classes of threat: bacteria, viruses, fungi, spores, biofilm
0
Toxic residue — breaks down to salt and water, non-corrosive

Hypochlorous-acid chemistry is recognized on the WHO list of effective biocides. Where an application calls for it, named-pathogen efficacy — including Listeria, Salmonella, and norovirus — is supported by data. We publish what the platform does, never how it is made.

Application matrix

A platform, not a product.

The same stabilized molecule addresses problems across industry, infrastructure, agriculture, and the environment. Find your operation below. Each one is a direct line to our team.

Anchor verticals

Lead applications

Additional fields of use

Where the platform extends

Under exploration

Frontier runway
Patent pending WHO-listed chemistry

Commercial role

EXCO Sciences is the exclusive global commercialization partner for StableHOCL™, across every field, application, and territory.

Inventors

Dr. Martin B. EksterInventor

Dr. Colinda L. EksterCo-Inventor

IP status

Patent pendingProprietary stabilization platform. We disclose what it does, never the formulation or mechanism.

We stabilize the unstable to protect life.

Tell us what you run. We'll tell you whether StableHOCL™ fits.